bearish

Ryman Healthcare - Running Ryman for Cash

268 Views26 Mar 2025 12:00
Broker
We value RYM using our annuity earnings including resale gains and a dividend discount model (DDM). We reinstate our rating at NEUTRAL.
What is covered in the Full Insight:
  • Introduction to Ryman's Strategy
  • Capital Raise and Cash Focus
  • Development and Resales
  • Earnings Forecast and Valuation
  • Market Outlook and Future Strategy
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 24-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x